Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Assertio Holdings, Inc. is a U.S.-based pharmaceutical company specializing in oncology, neurology, and pain management. It markets differentiated, approved products such as ROLVEDON, Sympazan, INDOCIN, Otrexup, SPRIX, and CAMBIA primarily through a sales force and omni-channel promotional model targeting hospitals, clinics, and pharmacies. Assertio relies on third-party manufacturing and focuses on patient-centric services, patent protection, and strategic product acquisitions to sustain competitive advantage and commercial growth.
This description was generated via AI from an annual report. Updated about 1 year ago.